1. X
  2. Dr. Bishoy M. Faltas
Log inSign up
Dr. Bishoy M. Faltas
13.2K posts
Dr. Bishoy M. Faltas profile banner
user avatar

Dr. Bishoy M. Faltas

@FaltasLab
Physician-Scientist. Chief Research Officer @EngIPM. Gellert-John P. Leonard Scholar, Associate Professor @WeillCornell. Husband & father. RTs ≠ endorsements
Manhattan, NY
faltaslab.weill.cornell.edu
Joined February 2015
8,621
Following
7,852
Followers
RepliesRepliesMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • Pinned
    user avatar
    Dr. Bishoy M. Faltas
    @FaltasLab
    Aug 1
    Thank you to @CBSNews for highlighting our #research! For many patients with muscle-invasive #BladderCancer, the standard of care is neoadjuvant systemic therapy followed by curative surgery to remove the bladder. For selected patients, bladder-preserving approaches are already
    user avatar
    CBS News
    @CBSNews
    Jul 31
    What if doctors could test cancer treatments on your tumor, without putting a single one of those treatments into your body? CBS News’ Riley Callanan reports.
    Image
    00:00
  • user avatar
    Dr. Bishoy M. Faltas
    @FaltasLab
    Aug 23
    Congratulations @UroDocAsh and IBCG board on the 20th anniversary of this important meeting that shapes #bladdercancer care and research. Looking forward to seeing everyone #IBCG26
    user avatar
    Ashish M. Kamat, MD, MBBS
    @UroDocAsh
    Aug 23
    Looking forward to welcoming colleagues, friends, patient advocates, regulators, and industry partners to Houston this week for #IBCG26. The strength of IBCG has always been honest discussion, respectful disagreement, and a shared commitment to improving bladder cancer care.
  • user avatar
    Dr. Bishoy M. Faltas
    @FaltasLab
    Aug 14
    Great opportunity to work with the amazing @montypal!
    user avatar
    Sumanta K. Pal, MD, FASCO
    @montypal
    Aug 13
    If anyone is interested in joining the #kidneycancer subsection of @GTumors, give me a holler! We meet on Fridays at 6 am PST - a time that seems to work for our global membership with attendees from #China (@yao_zhu_sh), #India (@drgaganprakash), #Morocco (@karima_oualla),
  • user avatar
    Dr. Bishoy M. Faltas
    @FaltasLab
    Aug 14
    Enjoyed being on the @Uromigos 🎙️podcast! Thanks @brian_rini @tompowles1 for the great conversation we had about investigator-initiated clinical trials. We discussed our journey from cell lines to a completed investigator-initiated clinical trial! #CLONEVO . We reminisced about
    Image
  • user avatar
    Dr. Bishoy M. Faltas
    @FaltasLab
    Aug 7
    Congratulations @DrScottTagawa and team @WCMGUcancer!
    user avatar
    Rohit Jain, MD
    @rohitjainMD
    Aug 7
    👏👏@DrScottTagawa and the entire #PSMAddition team on this 👍 @TheLancet ! A landmark ph 3 trial of ¹⁷⁷Lu-PSMA-617 in PSMA-positive #mhspc #mAPMN/S thelancet.com/journals/lance… #fdaapproved @WCMGUcancer @cnsternberg @FaltasLab
Advertisement
Advertisement